Natural compound could fight rheumatoid arthritis at its source

Scientists have discovered that a natural compound called obakulactone, derived from plant bark, can reduce joint swelling and protect cartilage in rats with rheumatoid arthritis. The compound works by regulating how cells process fatty acids.
Why it matters
This discovery offers a potential new therapeutic pathway for treating rheumatoid arthritis by targeting metabolic processes rather than just inflammation.
Scientists have identified a natural plant compound that could offer a surprising new approach to fighting rheumatoid arthritis. In experiments with rats, the substance reduced joint swelling, protected cartilage, and calmed harmful immune activity. Researchers also discovered that it works through an unexpected mechanism involving the way the body processes fats.
The findings, published in the journal Engineering , center on a compound called obakulactone (OL), a naturally occurring tetracyclic triterpenoid extracted from Phellodendri cortex , a type of plant bark. Tetracyclic triterpenoids are plant chemicals characterized by a structure containing four interconnected rings.
The researchers found that obakulactone helps restore balance to unsaturated fatty acids, which play important roles in cellular function and inflammation. It does this by promoting the breakdown of a protein called acyl coenzyme A thioesterase 1 (ACOT1), using the cell's natural protein disposal system, known as the ubiquitin‒proteasome pathway.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in